SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-18-028592
Filing Date
2018-04-30
Accepted
2018-04-30 16:34:32
Documents
6
Period of Report
2018-06-13
Effectiveness Date
2018-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A a18-2832_1def14a.htm DEF 14A 1019757
2 GRAPHIC g28321cai001.jpg GRAPHIC 128468
3 GRAPHIC g28321cai002.jpg GRAPHIC 99043
4 GRAPHIC g28321bci001.gif GRAPHIC 4924
5 GRAPHIC g28321bci002.gif GRAPHIC 2158
6 GRAPHIC g28321bci003.gif GRAPHIC 2611
  Complete submission text file 0001104659-18-028592.txt   1348031
Mailing Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901
Business Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901 203-653-3880
Loxo Oncology, Inc. (Filer) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36562 | Film No.: 18790391
SIC: 2834 Pharmaceutical Preparations